Document is current
Any future updates will be listed below
-
Authors
Haque, Farah https://orcid.org/0000-0002-5492-3164
Freniere, Christian https://orcid.org/0000-0003-2846-669X
Ye, Qiong
Mani, Nandini https://orcid.org/0000-0002-2025-9103
Wilson-Kubalek, Elizabeth M.
Ku, Pei-I
Milligan, Ronald A.
Subramanian, Radhika https://orcid.org/0000-0002-3011-9403
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R37GM052468)
American Cancer Society
Pew Charitable Trusts
Richard and Susan Smith Family Foundation
- License Information
-
More Information
Article History
Received: 9 January 2021
Accepted: 6 May 2022
First Online: 20 June 2022
Competing interests
: Massachusetts General Hospital has filed a provisional patent application (application number 63/089,770) covering the use of peptides inhibitors of glioma-associated oncogene derived from the coiled-coil dimerization domain of KIF7 that lists R.S., F.H., C.F. and Q.Y. as inventors. The remaining authors declare no competing interests.
